MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.vaccine.2025.127944

Медицинская библиотека · Vaccine · 2025

Rotasiil vaccine effectiveness against rotavirus-associated hospitalizations in the Democratic Republic of the Congo: comparison of multivariate logistic regression and inverse probability treatment weighting methods in a test-negative design.

Luhata Lungayo Christophe, Burnett Eleanor, Mulumba Audry, Milabyo Augustin, Nasaka Pablito, Adhaku Raymond, Volatier Etienne, Tate Jacqueline E, Parashar Umesh, Diallo Alpha Oumar, Burke Rachel M, Otomba John Samuel, Dommergues Marie-Aliette, Pukuta Elisabeth, Mwenda Jason M, Ngoy Francis, Ngoy Medard, Mosala Noela, Muteba Dominique, Domingo Dido Disengomoka, Ditekemena John, Launay Odile, Jouffroy Romain

СтатьяСравнительное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Multinational rotavirus vaccines (Rotarix and RotaTeq) are 43 %-65 % effective in preventing hospitalizations due to rotavirus disease in African countries. The Rotasiil vaccine (Serum Institute of India) offers a potentially cost-effective option but lacks vaccine effectiveness (VE) estimates in African settings. We estimated Rotasiil VE against rotavirus hospitalizations in the Democratic Republic of Congo (DRC) using unconditional multivariate logistic regression and inverse probability of treatment weighting (IPTW) to adjust confounding.

METHODS

We examined sentinel surveillance data from two hospitals in Kinshasa (January 1, 2020 to December 31, 2023) for children aged ≤59 months who sought care for acute diarrhea. We used a test-negative case-control design and calculated VE as [1 - adjusted odds ratio (OR) × 100] using unconditional multivariate logistic regression. We compared two approaches to adjust the OR for confounding. First, the OR was adjusted by including the covariates in the model. Second, the OR was adjusted using stabilized IPTW.

RESULTS

In total, 310 children aged 6 to 30 months were included in the full rotavirus vaccine dose analysis, of which 118 (38 %) were rotavirus positive. The median age was 10 months (range: 8-14), and the proportion of fully vaccinated children was 87 %. The VE measured between fully vaccinated versus unvaccinated children was 60 % (95 % CI: 20-80) by multivariate logistic regression and 79 % (95 % CI: 71-85) by IPTW.

CONCLUSION

Rotasiil vaccination under conditions of routine use effectively reduces rotavirus-associated diarrhea hospitalizations among children, supporting the ongoing use of rotavirus vaccine. The IPTW VE estimate was more precise than multivariate logistic regression but the confidence intervals overlapped, suggesting that the resulting VE estimates are not statistically different and the methods are complementary.

Для цитирования: Luhata Lungayo Christophe, Burnett Eleanor, Mulumba Audry, Milabyo Augustin, Nasaka Pablito, Adhaku Raymond, Volatier Etienne, Tate Jacqueline E, Parashar Umesh, Diallo Alpha Oumar, Burke Rachel M, Otomba John Samuel, Dommergues Marie-Aliette, Pukuta Elisabeth, Mwenda Jason M, Ngoy Francis, Ngoy Medard, Mosala Noela, Muteba Dominique, Domingo Dido Disengomoka, Ditekemena John, Launay Odile, Jouffroy Romain. Rotasiil vaccine effectiveness against rotavirus-associated hospitalizations in the Democratic Republic of the Congo: comparison of multivariate logistic regression and inverse probability treatment weighting methods in a test-negative design.. Vaccine. 2025. DOI: 10.1016/j.vaccine.2025.127944.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.